Bio-Techne Corp. Stock
Price
Target price
€50.00
€50.00
-0.990%
-
-0.990%
€60.82
30.12.25 / Tradegate
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bio-Techne Corp. Stock
Bio-Techne Corp. shows a slight decrease today, losing €0.000 (-0.990%) compared to yesterday.
Bio-Techne Corp. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 60 € shows a slightly positive potential of 20.0% compared to the current price of 50.0 € for Bio-Techne Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -0.990% | -0.990% | -10.714% | -28.058% | -28.058% | -36.306% | - |
| Icu Medical Inc. | -0.800% | 0.000% | -1.575% | -14.966% | -14.966% | -15.541% | -28.161% |
| Bio-Rad Labs Inc. A | 0.590% | 0.272% | -10.264% | -17.892% | -17.892% | -34.857% | -45.128% |
| Neogen Corp. | 0.820% | 0.820% | 18.269% | -48.750% | -48.750% | - | - |
Comments
Bio-Techne (NASDAQ:TECH) was given a new $72.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Argus from $65.00 to $68.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at UBS Group AG from $65.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
